Skip to content

← 21 Aug 2026 · Long-term Top 10 — Health Care

Long-term Top 10 — Health Care — what changed on 24 Aug 2026

A dated record of one session: what entered or left, what moved inside the ten and by how much, who is closest to the boundary, and how the list did against its benchmark. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100.

The long-term score is a published weighted sum of percentile ranks, rebalanced on the first trading day of each month. A list is a published formula and its output, not a recommendation. Method version 3.

Get this list's changes by email

Who entered, who left, and the reason — with the score moves behind it.

Sign in to subscribe Subscriptions are available to signed-in accounts while email delivery is being set up.

Informational only — not financial advice. The daily email has not started yet — subscribing now puts you on the list for the first one. Unsubscribe in one click.

Membership

No company entered or left on 24 Aug 2026. The next scheduled change is at this list's next rebalance.

Inside the ten

Not compared with the previous session, 21 Aug 2026: those rows were scored under method version 2 and this session under version 3, and the formula changed between them, so a score is only comparable within one version.

CompanyRankScorePillar that moved most
Lilly (Eli) (LLY)370.4 0.0no pillar moved materially
Amgen (AMGN)767.0 0.0no pillar moved materially
Johnson & Johnson (JNJ)1664.5 0.0no pillar moved materially
ResMed (RMD)1763.5 0.0no pillar moved materially
Bristol Myers Squibb (BMY)1963.3 0.0no pillar moved materially
LIGAND PHARMACEUTICALS INC (LGND)2162.6 0.0no pillar moved materially
Royalty Pharma (RPRX)2262.5 0.0no pillar moved materially
NATIONAL HEALTHCARE CORP (NHC)2961.2 0.0no pillar moved materially
Quest Diagnostics (DGX)3060.4 0.0no pillar moved materially
West Pharmaceutical Services (WST)3558.4 0.0no pillar moved materially

At the edge

Knocking

  • AURINIA PHARMACEUTICALS INC (AUPH) scores 17.0 above the lowest member — the sector cap, not the score, is what is keeping it out
  • Incyte (INCY) scores 15.0 above the lowest member — the sector cap, not the score, is what is keeping it out

Closest to the exit

Ranked against 195 eligible Health Care companies on this session. A company at the edge is a company near a boundary, not a prediction that it will cross one.

Against the benchmark

SPY is the S&P 500 ETF — the US large-cap market average.

−0.2% since the previous session (2026-08-21), against −0.3% for SPY — 0.1 points ahead of the benchmark. Tracked since 2026-08-18.

+1.8% since 2026-08-18, against −0.5% for SPY — 2.3 points ahead of the benchmark. Tracked since 2026-08-18.

Both curves are total return through 24 Aug 2026: a distribution buys more of the company that paid it, on the benchmark as much as on the list.

Since start
+1.8%
SPY −0.5% · +2.3 points

More

Informational only — NOT financial advice.

Research stocks in your own words.

Informational only — NOT financial advice.

ScreenersBlogPrivacyiOS app